Design and Characterization of Endostatin-Loaded Nanoparticles for In Vitro Antiangiogenesis in Squamous Cell Carcinoma

Table 2

Drug-loading capacity and entrapment efficiency.

Formulations	Entrapment efficiency	Loading capacity (%)
F1	0.943	31.43
F2	0.953	31.77
F3	0.975	32.50
F4	0.928	30.93
F5	0.984	32.80
F6	0.980	32.67
F7	0.947	31.57
F8	0.973	32.43
F9	0.959	31.97
F10	0.966	32.20
F11	0.963	32.10
F12	0.969	32.30
F13	0.981	32.70
F14	0.971	32.37
F15	0.964	32.13